Baseline characteristics of patients with COPD at their first exacerbation-related hospitalisation
| Patients | 82 964 |
| Age, years, mean±sd | 72.2±10.2 |
| Sex | |
| Male | 39 716 (47.9) |
| Female | 43 248 (52.1) |
| Education# | |
| Lower secondary education | 45 900 (61.0) |
| Upper secondary education | 22 985 (30.6) |
| Tertiary education or Bachelor's degree | 5246 (7.0) |
| Master's or Doctoral degree | 1083 (1.4) |
| Cohabitation status¶ | |
| Living alone | 39 765 (53.8) |
| Living together | 34 178 (46.2) |
| Inhaled medication | |
| SABA | 7160 (8.6) |
| LAMA | 4490 (5.4) |
| LABA | 2704 (3.3) |
| ICS | 8105 (9.8) |
| LAMA/LABA | 1120 (1.3) |
| LAMA/ICS or LABA/ICS | 17 031 (20.5) |
| Triple therapy | 13 510 (16.3) |
| Total | 54 120 (65.2) |
| No treatment | 28 844 (34.8) |
| Comorbidities | |
| Chronic heart failure | 13 692 (16.5) |
| (Complicated) diabetes | 10 137 (12.2) |
| Cerebrovascular disease | 9059 (10.9) |
| Peripheral vascular disease | 8293 (10.0) |
| Cancer | 7886 (9.5) |
| Myocardial infarction | 6551 (7.9) |
| Depression | 4334 (5.2) |
| Peptic ulcer disease | 4264 (5.1) |
| Rheumatic diseases | 3459 (4.2) |
| Chronic renal disease | 2822 (3.4) |
| Dementia | 2342 (2.8) |
| Anxiety | 2310 (2.8) |
| (Severe) hepatic disease | 1523 (1.8) |
| Metastatic cancer | 1102 (1.3) |
| Hemiplegia | 277 (0.3) |
| AIDS | 82 (0.1) |
| Number of comorbidities | |
| 0 | 35 256 (42.5) |
| 1 | 20 499 (24.7) |
| 2 | 12 901 (15.6) |
| ≥3 | 14 308 (17.2) |
| Characteristics of the index event | |
| Time until discharge, days, median (interquartile range) | 4 (2–8) |
Data are presented as n (%) unless otherwise stated. SABA: short-acting β2-agonist; LAMA: long-acting muscarinic antagonist; LABA: long-acting β2-agonist; ICS: inhaled corticosteroid. #: n=75 214; ¶: n=73 943.